Frequently Asked Questions
The market is segmented based on , By Disease Type (Black Disease, Blackleg, Malignant Oedema, Tetanus, Botulism, Others), Animal Species (Cattle, Sheep, Poultry, Horses, Others), Exotoxins (Enterotoxins, Neurotoxins, Others), Treatment (Tetanus toxoid, Multivalent Vaccine, Antibiotics, Others), End-Users (Veterinary Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
.
The Global Clostridial Diseases Market size was valued at USD 2.22 USD Billion in 2021.
The Global Clostridial Diseases Market is projected to grow at a CAGR of 12% during the forecast period of 2022 to 2029.
The major players operating in the market include Boehringer Ingelheim International GmbH, Zoetis, Elanco, Merck & Co. , Phibro Animal Health Corporation, Virbac, Vetoquinol, HIPRA, Ceva, Dechra, Kyoritsuseiyaku Corporation, CHINA ANIMAL HUSBANDRY GROUP, Endovac Animal Health, Zydus Group, Indian Immunologicals Pvt. , UCBVET Saúde e Bem Estar Animal, American Reagent , Neogen Corporation, Huvepharma.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
